CYP2C19 is a cytochrome P450 enzyme primarily involved in metabolizing drugs such as clopidogrel, omeprazole, and certain antidepressants (e.g., citalopram). There is no direct evidence linking CYP2C19 variants to the physiological stress response (cortisol, adrenaline). However, altered drug metabolism could indirectly affect stress perception or coping – for example, if a medication is less effective in rapid metabolizers or causes more sedation in poor metabolizers. The evidence is mostly mechanistic or from pharmacogenetic studies, not from controlled stress experiments. A consumer DNA test alone cannot determine your personal stress vulnerability. Always consult a physician before adjusting any medication based on your CYP2C19 status. Clinical reliability is limited because consumer tests may miss rare or ancestry-specific alleles.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-98c7e715a9fd91e38346c8a6